Horizon Discovery engages in gene editing and gene modulation for life sciences, self-described as a leader in the field.

Horizon Discovery

IPhone / Mobile Compatible

Viewport Meta

Google Tag Manager

Euro

DNSSEC

Cloudflare JS

CDN JS

AJAX Libraries API

Amazon Virginia Region

Microsoft

Owner

Ron Fisher

Senior Director, Information Technology

Glenn Grieves

Director of Software Development, eCommerce

Ian Lane

Associate Director of Product Management - Screening Services

James Goldmeyer

Digital Marketing Director

Jason Johnson

Director Bioproduction Commercial Licensing

Josh Nelson

Finance Director at Horizon Discovery

Mark Mortell

Senior Software Engineer/Director

Peter Grossman

Director, Commercial Excellence

Urszula Caney

Director, Genome Engineering & Stem Cell Center (GESC@MGI)

Xiaoxia Cui

Darrin Disley

Jonathan Milner

Ian Gilham

Vishal Gulati

Susan Searle

Richard Vellacott

Chief Financial Officer

Jayesh Pankhania

Alberto Bardelli

Founder

Andrew Cohen

Head of Global Marketing

Emily Anderson

Senior Scientist

Jamie Freeman

Corporate Innovation Partner

Chris Lowe

Head of Research Operations

Genetics Companies With More Than 10 Employees

Europe Acquired Companies With More Than $50M in Revenue

Biopharma Acquired Companies

Investors Active in Cambridge, Cambridgeshire

Horizon Discovery Group PLC is a UK life science company that uses gene editing and gene modulation platforms to produce cells, applying them in research and clinical applications that advance human health. The Company’s gene editing and gene modulation platform, are able to alter almost any DNA sequence or RNA transcription, has generated a catalogue of over 1,000,000 cell and reagent products that help researchers recapitulate the genetic and protein anomalies found in diseases like cancer. These models have been adopted by c12, 000 organizations to better understand of the predictors and drivers of disease and drug response, and by Horizon in a range of services offered to customers, as well as in the Company’s own research R&D pipeline.

ValueAct Capital

Post-IPO Equity - Horizon Discovery

Future Fifty

Non Equity Assistance - Horizon Discovery

Venture Round - Horizon Discovery

MVM Life Science Partners

Series C - Horizon Discovery

Series A - Horizon Discovery

Cambridge

Cambridgeshire

United Kingdom

Europe

Sigma-Aldrich Licenses CRISPR-Cas9 Tech to Horizon Discovery

PerkinElmer hits the checkbook again, this time doling out $260M for next-gen therapy bioservices firm

Horizon Discovery Licenses Gene-Edited Cell Line to Sanyou Biopharmaceuticals

US swallows another Cambridge gem as Horizon sells to PerkinElmer for $383m

PerkinElmer buys out British gene editing player for $383M, boosting its diagnostics and genomic capabilites

Perkinelmer snags Horizon Discovery for $383M

Horizon Discovery–PerkinElmer: investment, 202011– cash tender offer £296m ($383m) representing total enterprise value of £284m ($368m)

Why Horizon Discovery Group plc (LON:HZD) Could Be Worth Watching

Horizon Discovery H1 Revenues Fall 14 Percent

United States

North America

China

Asia

Taiwan

Australia

Oceania

HTML5

Apache Server

Google Drive

Comodo PositiveSSL Certificates

jQuery

Modernizr

Adobe Fonts

HubSpot Forms

Lead Flows

GoDaddy

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 17, 2024 6:11 AM	5a5bacb3
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 17, 2024 6:11 AM	db3f713a
crunchbase trigger	general	Oct 28, 2024 1:51 PM	f15ec802
crunchbase profile	general	Oct 29, 2024 11:31 AM	28678b8d
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	3e40a134
peers	general	Oct 17, 2024 6:11 AM	4d5e01de
news basic	general	Oct 17, 2024 6:11 AM	e4aa0b19
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:HORIZONDISCOVERY

Horizon Discovery